Combining a fasting mimicking diet with chemotherapy for leukemia patients
Official title: The Effect of Fasting Mimicking Diet With Chemotherapy on the Number of Blasts and Platelets and Quality of Life in Patients With Acute Lymphoid Leukemia and Acute Myeloid Leukemia
Run by National Nutrition and Food Technology Institute · NCT06353698 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if combining a fasting mimicking diet with chemotherapy can improve treatment results and quality of life for patients with acute lymphoid and acute myeloid leukemia.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | National Nutrition and Food Technology Institute Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Tehran, Middle East and 1 other locations) |
| Trial ID | NCT06353698 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals recently diagnosed with acute leukemia who are set to begin chemotherapy and have a BMI greater than 18.5.
✕Probably not a fit
Patients with diabetes, metastases to other organs, or those unwilling to comply with the study requirements may not benefit from this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of a fasting mimicking diet in conjunction with chemotherapy on patients diagnosed with acute lymphoid leukemia and acute myeloid leukemia. The study aims to assess changes in the number of leukemia blasts, platelet counts, and overall quality of life for participants. By integrating dietary interventions with standard chemotherapy, the trial seeks to explore potential synergistic effects that could enhance treatment outcomes. Participants will be monitored throughout the intervention to evaluate both clinical and quality of life metrics.
Why it matters
Potential benefit: If successful, this approach could improve treatment efficacy and quality of life for patients undergoing chemotherapy for leukemia.
How similar studies have gone: While the combination of dietary interventions with chemotherapy is an emerging area of interest, this specific approach has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * People who have recently been diagnosed with acute leukemia pathology and have been prescribed chemotherapy * Willingness to cooperate * BMI \>18.5 Exclusion Criteria: * diabetes * metastases to other organ * Unwillingness to continue the study by patients
Where it's running
-
Azita Hekmatdoost
Tehran, Middle East, Iran, Islamic Republic of Recruiting -
Ehsan Hejazi
Tehran, Iran, Islamic Republic of Recruiting
Study contacts
- Principal investigator: Ehsan Hejazi, PhD — Beheshti University of Medical Sciences
- Study coordinator: Ehsan Hejazi, PhD
- Email: ehsanhejazi@gmail.com
- Phone: 00989121530775
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Strength Training for Kids with Acute Lymphoblastic Leukemia and Lymphoblastic L lymphoma
Researchers are testing a structured strength-training program for children and teens recently diagnosed with ALL or lymphoblastic lymphoma to see if it helps with weight gain and physical function during treatment.
-
Cord blood transplant for children and young adults with blood cancers.
This study will test whether a cord blood transplant given as a first or second transplant can help children and young adults with leukemia, myelodysplasia, or lymphoma who lack a matched donor.
-
Cohort for people with chronic myelomonocytic leukemia
This project will collect blood and bone marrow samples from adults with chronic myelomonocytic leukemia at diagnosis and during disease changes to create an anonymized biobank researchers can use to test new questions.
-
Triple-drug approach for AML using eganelisib with azacitidine and venetoclax
This early-stage trial tests whether adding eganelisib to azacitidine and venetoclax can be safe and show signs of benefit in adults with acute myeloid leukemia.
-
Guided spiritual care sessions for adults with acute leukemia
This will test whether adding guided spiritual care sessions helps adults hospitalized for initial treatment of acute leukemia compared with standard inpatient spiritual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.